Vimian Group: third-quarter revenue rises 15% to €120.3 million
Vimian Group reported third-quarter revenue of €120.3 million and adjusted EBITA of €29.2 million, according to TradingView. The company also signed a deal for Norfolk Medical Products.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to TradingView, Vimian Group posted third-quarter revenue of €120.3 million, up 15% from a year earlier. Organic growth reached 11%, so most of the increase did not come from acquisitions.
Adjusted EBITA rose 14% year on year to €29.2 million, giving a margin of 24.3%.
After the quarter ended, the company agreed to acquire Norfolk Medical Products, which will expand its presence in soft tissue surgery.
why it matters
The key points are the 11% organic growth and profit rising almost as fast as revenue. The deal terms and updated guidance were not disclosed in the material, so it is hard to judge the acquisition's effect on financial results for now.
tags
instruments
sources
- Vimian Group (VIMIAN) Q3 Revenue €120.3M, Up 15%; Adj. EBITA €29.2M — TradingView, 22 October 2026 at 05:45 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗